ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Metabolism >Phosphorylase inhibitors >CP 91149

CP 91149

CP 91149 Structure
CAS No.
186392-40-5
Chemical Name:
CP 91149
Synonyms
CS-231;CP 91149;CP-91149 CP91149;CP 91149 USP/EP/BP;5-chloro-N-((2S,3R)-4-(dimethylamino)-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-1H-indole-2-carboxamide;5-Chloro-N-[(1S,2R)-3-(diMethylaMino)-2-hydroxy-3-oxo-1-(phenylMethyl)propyl]-1H-indole-2-carboxaMide;[R-(R*,S*)]-5-Chloro-N-[3-(diMethylaMino)-2-hydroxy-3-oxo- 1-(phenylMethyl)propyl]-1H-indole-2-carboxaMide
CBNumber:
CB22543734
Molecular Formula:
C21H21ClN3O3
Molecular Weight:
398.86274
MOL File:
186392-40-5.mol
MSDS File:
SDS
Modify Date:
2023/6/8 9:02:20

CP 91149 Properties

Melting point 190-192°C
storage temp. 2-8°C
solubility DMSO: >20mg/mL
form powder
color white to off-white
Stability Hygroscopic

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P264-P270-P301+P312-P330-P501
Hazard Codes  Xn
Risk Statements  22
WGK Germany  3
NFPA 704
0
2 0

CP 91149 price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) PZ0104 CP-91149 ≥98% (HPLC) 186392-40-5 5MG ₹14667.88 2022-06-14 Buy
Sigma-Aldrich(India) PZ0104 CP-91149 ≥98% (HPLC) 186392-40-5 25MG ₹58314.28 2022-06-14 Buy
Product number Packaging Price Buy
PZ0104 5MG ₹14667.88 Buy
PZ0104 25MG ₹58314.28 Buy

CP 91149 Chemical Properties,Uses,Production

Description

CP 91,149 is an inhibitor of human liver glycogen phosphorylase a (LGPa), muscle glycogen phosphorylase a (MGPa), and MGPb (IC50s = 0.13, 0.2, and 0.3 μM, respectively, in the presence of glucose). CP 91,149 is 5- to 10-fold less potent in the absence of glucose. In vitro, it inhibits glucagon-stimulated glycogenolysis in primary human hepatocytes (IC50 = 2.1 μM) and increases glycogen synthesis in rat hepatocytes at a concentration of 2.5 μM in the presence of 5 mM glucose. CP 91,149 inhibits brain GP (IC50 = 0.5 μM) and, at a concentration of 30 μM, inhibits glycogen accumulation and proliferation of A549 non-small cell lung carcinoma (NSCLC) cells that express endogenous brain GP. In vivo, CP 91,149 (25 mg/kg, p.o.) lowers the plasma glucose level in diabetic ob/ob mice within 3 hours of administration without producing hypoglycemia, but has no effect on normoglycemic, non-diabetic mice.

Chemical Properties

White Solid

Uses

Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression. Antitumor agent.

CP 91149 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 102)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Alpha Biopharmaceuticals Co., Ltd +86-15542445688 China 888 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29825 58 Inquiry
Hebei Mojin Biotechnology Co., Ltd +8613288715578 China 12452 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 24407 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
Nextpeptide Inc +86-0571-81612335 +8613336028439 China 19915 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
Wuhan Topule Biopharmaceutical Co., Ltd +8618327326525 China 8474 58 Inquiry
Jilin Chinese Academy of Sciences-yanshen Technology +undefined18143011203 China 42057 58 Inquiry

CP 91149 Spectrum

186392-40-5(CP 91149)Related Search:

[R-(R*,S*)]-5-Chloro-N-[3-(diMethylaMino)-2-hydroxy-3-oxo- 1-(phenylMethyl)propyl]-1H-indole-2-carboxaMide 5-Chloro-N-[(1S,2R)-3-(diMethylaMino)-2-hydroxy-3-oxo-1-(phenylMethyl)propyl]-1H-indole-2-carboxaMide CP 91149 5-chloro-N-((2S,3R)-4-(dimethylamino)-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-1H-indole-2-carboxamide CP 91149 USP/EP/BP CS-231 CP-91149 CP91149 186392-40-5 Inhibitors Aromatics Chiral Reagents Heterocycles Intermediates & Fine Chemicals Pfizer compounds Pharmaceuticals peptides